Think it's going to take 6 weeks?
You need to diet for 12 weeks.
But you can get just as effective muscle-building results from using machines/supported movements.
Focus on improving these two things.
Everything else is secondary.
Any longer than this and it's the law of diminishing returns for muscle gain.
Lift with a 3-0-1 tempo.
3-second eccentric (muscle is lengthening)
0-second pause (the muscle is fully lengthened)
1 second concentric (muscle is shortening)
But you'll need to train close to it.
Always lift with 1-2 reps left in the tank.
Lifting weights is my stress relief for the brain.
If you're in your first 1-2 years of training, you should be increasing the weight on your compound lifts every week.
6-12 reps are the ideal rep range for compounds.
10-20 reps are the ideal rep range for isolations.
Arms, calves and shoulders can be trained 3x per week.
If you want to maximise strength, rest for up to 2-3 minutes between sets.
This reduces fatigue and allows your body hit the next set as hard as possible.
Being dehydrated will drastically impair your gym performance.
Drink more H20 if you want to lift big.
Stop changing shit up every week.
This isn't sexy but it gets results.
If you want to maximise strength, lift in the afternoon after you've consumed 1-2 meals.
More squats, hip thrusts and weighted glute bridges solve this.
Want bigger guns?
Do fewer bicep curls and more tricep pushdowns and close grip bench press.
Add in more pull-ups, rear delt flies, dead hangs, face pulls and Romanian deadlifts to combat this.
This will help you stand/sit more upright and fix your back pain.
I'm looking to coach 3 entrepreneurs or high performers into the best shape of their life in just 1-3 hours per week. 🔥
Want in?
Shoot me a DM & let's chat.👇
https://t.co/KUv8QYcUqf
More from All
You May Also Like
Keep dwelling on this:
Further Examination of the Motif near PRRA Reveals Close Structural Similarity to the SEB Superantigen as well as Sequence Similarities to Neurotoxins and a Viral SAg.
The insertion PRRA together with 7 sequentially preceding residues & succeeding R685 (conserved in β-CoVs) form a motif, Y674QTQTNSPRRAR685, homologous to those of neurotoxins from Ophiophagus (cobra) and Bungarus genera, as well as neurotoxin-like regions from three RABV strains
(20) (Fig. 2D). We further noticed that the same segment bears close similarity to the HIV-1 glycoprotein gp120 SAg motif F164 to V174.
https://t.co/EwwJOSa8RK
In (B), the segment S680PPRAR685 including the PRRA insert and highly conserved cleavage site *R685* is shown in van der Waals representation (black labels) and nearby CDR residues of the TCRVβ domain are labeled in blue/white
https://t.co/BsY8BAIzDa
Sequence Identity %
https://t.co/BsY8BAIzDa
Y674 - QTQTNSPRRA - R685
Similar to neurotoxins from Ophiophagus (cobra) & Bungarus genera & neurotoxin-like regions from three RABV strains
T678 - NSPRRA- R685
Superantigenic core, consistently aligned against bacterial or viral SAgs
Further Examination of the Motif near PRRA Reveals Close Structural Similarity to the SEB Superantigen as well as Sequence Similarities to Neurotoxins and a Viral SAg.
The insertion PRRA together with 7 sequentially preceding residues & succeeding R685 (conserved in β-CoVs) form a motif, Y674QTQTNSPRRAR685, homologous to those of neurotoxins from Ophiophagus (cobra) and Bungarus genera, as well as neurotoxin-like regions from three RABV strains
(20) (Fig. 2D). We further noticed that the same segment bears close similarity to the HIV-1 glycoprotein gp120 SAg motif F164 to V174.
https://t.co/EwwJOSa8RK

In (B), the segment S680PPRAR685 including the PRRA insert and highly conserved cleavage site *R685* is shown in van der Waals representation (black labels) and nearby CDR residues of the TCRVβ domain are labeled in blue/white
https://t.co/BsY8BAIzDa

Sequence Identity %
https://t.co/BsY8BAIzDa
Y674 - QTQTNSPRRA - R685
Similar to neurotoxins from Ophiophagus (cobra) & Bungarus genera & neurotoxin-like regions from three RABV strains
T678 - NSPRRA- R685
Superantigenic core, consistently aligned against bacterial or viral SAgs
